Business ❯Pharmaceutical Industry

Market Competition

Drug Pricing Novo Nordisk Drug Development Obesity Treatments Eli Lilly Drug Sales Generic Drugs Drug Approval Pricing Strategies Telehealth Services Pricing Branding Drug Alternatives Drug Efficacy Product Launches Weight Loss Drug Market RSV Vaccines Vaccine Market GLP-1 Market Weight Loss Drugs Stock Performance Eli Lilly vs Novo Nordisk Research and Development

Novo Nordisk Introduces $499 Wegovy Option for Uninsured Patients

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

Eli Lilly Fights Back Against Compounded Tirzepatide Amid FDA Supply Resolution

Bernie Sanders and Elon Musk Unite on Lowering Ozempic Prices

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial

Weight Loss Drugs Significantly Reduce COVID-19 Mortality

Compounded Weight Loss Drugs Raise Safety and Ethical Concerns

Viking Therapeutics Advances Weight-Loss Drug, Shaking Up Market Leaders

Eli Lilly's Mounjaro Outperforms Novo Nordisk's Ozempic in Weight Loss Study

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients

Pfizer Seeks FDA Approval for RSV Vaccine in Young Adults

Viking Therapeutics' New Weight Loss Drug Shows Promising Trial Results